Clinical trials sponsored by H. Lee Moffitt Cancer Center and Research Institute

Phase breakdown

Conditions studied

Recruiting trials led by H. Lee Moffitt Cancer Center and Research Institute

• A First-in-Human Study of FID-022 in Solid Tumor Patients
  NCT07249775 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma
  NCT04741997 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC
  NCT06193486 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 1 location
• Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma
  NCT06961357 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer
  NCT05504707 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Ending Tobacco Use Through Interactive Tailored Messaging for Cambodian People Living With HIV/AIDS
  NCT05746442 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations
  NCT05687188 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Evaluation and Outcomes of SAVI Scout MD for Localized Breast Surgery
  NCT07686250 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
• IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients
  NCT04562129 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening
  NCT06745895 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 75 Years · Sex: All (male and female) · 1 location
• Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma
  NCT06295159 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores
  NCT03495427 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: Male · 1 location
• Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy
  NCT06435351 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma
  NCT07276386 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC
  NCT07476001 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer
  NCT06833502 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer
  NCT06423963 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• SR & Abemaciclib With/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases
  NCT04923542 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
  NCT06409390 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
• Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
  NCT06121180 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab
  NCT05325632 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of Screening Brain MRIs in Stage IV Breast Cancer
  NCT05115474 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• The MIND-BC Study: MIND Diet for Breast Cancer Cognition
  NCT07018986 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
  NCT04275557 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 3 locations

Common questions

How many trials is H. Lee Moffitt Cancer Center and Research Institute recruiting for?

H. Lee Moffitt Cancer Center and Research Institute is the lead sponsor of 24 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.